Announcements Trials
Browse Landscape

Status

Completed 112Recruiting 40Unknown 29Terminated 25Active not recruiting 13Withdrawn 8Not yet recruiting 7Enrolling by invitation 2Temporarily not available 1Suspended 1No longer available 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Breast 1

Conditions

Ovarian Neoplasms 12Uterine Cervical Neoplasms 7Endometrial Neoplasms 6Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Peritoneal Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Breast Neoplasms 3Vulvar Neoplasms 2Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Lung Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Ovarian Epithelial 2Vulvar Diseases 1Uterine Neoplasms 1Tissue Adhesions 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Ovarian Cysts 1Osteosarcoma 1Obesity 1Mesothelioma, Malignant 1Melanoma 1Malnutrition 1Lichen Sclerosus et Atrophicus 1

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Uterine Neoplasms × Gynecologic × Clear all
NCT03987555 2026-03-18

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Wake Forest University Health Sciences

Suspended
22 enrolled
BreastGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡